Publication:
Epi-miRNAs: regulators of the histone modification machinery in human cancer

dc.contributor.coauthorSohrabi, B.
dc.contributor.coauthorMosallaei, M.
dc.contributor.coauthorNariman Saleh Fam, Z.
dc.contributor.coauthorBastami, M.
dc.contributor.coauthorMansoori, Y.
dc.contributor.coauthorDaraei, A.
dc.contributor.coauthorZununi Vahed, S.
dc.contributor.coauthorNavid, S.
dc.contributor.coauthorSaadatian, Z.
dc.contributor.coauthorJamialahmadi, T.
dc.contributor.coauthorTeng, Y.
dc.contributor.coauthorSahebkar A.
dc.contributor.departmentKUTTAM (Koç University Research Center for Translational Medicine)
dc.contributor.kuauthorMortazavi, Deniz
dc.contributor.schoolcollegeinstituteResearch Center
dc.date.accessioned2024-11-09T12:18:15Z
dc.date.issued2022
dc.description.abstractCancer is a leading cause of death and disability worldwide. Epigenetic deregulation is one of the most critical mechanisms in carcinogenesis and can be classified into effects on DNA methylation and histone modification. MicroRNAs are small noncoding RNAs involved in fine-tuning their target genes after transcription. Various microRNAs control the expression of histone modifiers and are involved in a variety of cancers. Therefore, overexpression or downregulation of microRNAs can alter cell fate and cause malignancies. In this review, we discuss the role of microRNAs in regulating the histone modification machinery in various cancers, with a focus on the histone-modifying enzymes such as acetylases, deacetylases, methyltransferases, demethylases, kinases, phosphatases, desumoylases, ubiquitinases, and deubiquitinases. Understanding of microRNA-related aberrations underlying histone modifiers in pathogenesis of different cancers can help identify novel therapeutic targets or early detection approaches that allow better management of patients or monitoring of treatment response.
dc.description.fulltextYES
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.openaccessYES
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipN/A
dc.description.versionPublisher version
dc.description.volume2022
dc.identifier.doi10.1155/2022/4889807
dc.identifier.eissn1687-8469
dc.identifier.embargoNO
dc.identifier.filenameinventorynoIR03443
dc.identifier.issn1687-8450
dc.identifier.quartileQ2
dc.identifier.scopus2-s2.0-85124007181
dc.identifier.urihttps://hdl.handle.net/20.500.14288/1452
dc.identifier.wos769753800001
dc.keywordsTranscription factor EZH2
dc.keywordsPolycomb repressive complex 2
dc.keywordsEpigenetics
dc.language.isoeng
dc.publisherHindawi
dc.relation.grantnoNA
dc.relation.ispartofJournal of Oncology
dc.relation.urihttp://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/10237
dc.subjectOncology
dc.titleEpi-miRNAs: regulators of the histone modification machinery in human cancer
dc.typeReview
dspace.entity.typePublication
local.contributor.kuauthorMortazavi, Deniz
local.publication.orgunit1Research Center
local.publication.orgunit2KUTTAM (Koç University Research Center for Translational Medicine)
relation.isOrgUnitOfPublication91bbe15d-017f-446b-b102-ce755523d939
relation.isOrgUnitOfPublication.latestForDiscovery91bbe15d-017f-446b-b102-ce755523d939
relation.isParentOrgUnitOfPublicationd437580f-9309-4ecb-864a-4af58309d287
relation.isParentOrgUnitOfPublication.latestForDiscoveryd437580f-9309-4ecb-864a-4af58309d287

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
10237.pdf
Size:
1.81 MB
Format:
Adobe Portable Document Format